medicine

In response to the results of the vote on a UN resolution continuing to allow cross-border aid into Syria, Oxfam’s Head of Office in New York, Brenda Mofya said: “The UN Security Council’s decision to renew the cross-border resolution for only six months is deeply disappointing and could potentially leave more than four million people in northwest Syria without the assistance they depend upon to survive when the harsh winter months arrive."

New Oxfam report: The proliferation of substandard medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need.

Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.